The latest effective drug for the treatment of chronic eczema is Dupliyuzumab, and it is recommended to follow the doctor’s instructions and use the drug under the guidance of a professional.
Chronic eczema is a chronic inflammatory skin disease with a marked tendency to ooze. Dupliyuzumab is used to treat moderate to severe atopic dermatitis in adults who are not well controlled with topical or oral medications, or for whom topical or oral medications are not recommended. It is the latest effective medication available for the treatment of chronic eczema.
Dupliyuzumab may have adverse reactions such as conjunctivitis, blepharitis, oral herpes, eosinophilia, infection, and should not be used in combination with topical corticosteroids. Dupliyuzumab should be used with caution in the elderly, pregnant and lactating women, and patients with hepatic or renal insufficiency. It is contraindicated for those who have hypersensitivity to the active ingredients or other excipients of the product.
It is recommended that patients with eczema consult a doctor in a timely manner and follow the doctor’s instructions for treatment and medication.